Single-Cell Transcriptomic Profiling of Peripheral Blood in a Patient with Progressive Thyroid Eye Disease Following Total Thyroidectomy

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/genes17091143
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Thyroid eye disease (TED) is an autoimmune inflammatory disorder of the orbit closely associated with thyroid dysfunction. Total thyroidectomy is traditionally expected to attenuate the autoimmune cascade, yet some patients continue to progress after surgery, which challenges this paradigm and points to a potentially autonomous orbital immune response. To investigate this, we performed single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from a 47-year-old woman with severe, glucocorticoid-refractory TED, four years after total thyroidectomy, and compared her immune landscape with that of an age- and sex-matched healthy control. The patient’s peripheral blood showed a clear shift toward an active, stress-associated inflammatory state: pro-inflammatory mediators, immediate-early response transcription factors (FOS, JUNB, FOSB, TNFAIP3), and survival-related genes (CXCR4, DDIT4) were all upregulated. Gene Set Enrichment Analysis (GSEA) pointed to different mechanisms across cell types—myeloid cells were enriched for IL-6/JAK/STAT3 and TNF-α signaling, activated T cells for oxidative phosphorylation and mTORC1 signaling—while B lymphocytes and NK cells showed the opposite pattern, with reduced inflammatory and metabolic activity. One possible explanation is a “tissue-drainage” effect, where the most pathogenic lymphocytes leave the bloodstream and migrate into the inflamed orbital tissue along chemokine gradients. Together, these findings point to the CXCR4/CXCL12 axis and cellular stress pathways as candidate therapeutic targets, though as a single-case observation this remains preliminary and requires validation in larger cohorts, at the protein level, and in functional in vitro/in vivo studies.